Romainville, France

Nicolas Luc Sabourault

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Nicolas Luc Sabourault

Introduction

Nicolas Luc Sabourault is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. With a total of 6 patents to his name, Sabourault's work has the potential to impact many lives.

Latest Patents

One of his latest patents involves the development of salts and pharmaceutical compositions for the treatment of inflammatory disorders. This invention discloses salts of a Compound 1 that are useful in the prophylaxis and treatment of various inflammatory conditions, autoimmune diseases, proliferative diseases, allergies, transplant rejection, and diseases associated with cartilage homeostasis. His innovative approach addresses critical health issues, including congenital cartilage malformations and diseases linked to hypersecretion of IL6 or interferons.

Career Highlights

Throughout his career, Sabourault has worked with prominent companies in the pharmaceutical industry, including Galapagos NV and Alfasigma S.p.A. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in his field.

Collaborations

Some of his notable coworkers include Piet Wigerinck and Carla De Faveri. Their collaborative efforts have likely played a role in advancing the innovative projects that Sabourault has been involved in.

Conclusion

Nicolas Luc Sabourault's contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…